BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cioffi M, Rosa AD, Serao R, Picone I, Vietri MT. Laboratory markers in ulcerative colitis: Current insights and future advances. World J Gastrointest Pathophysiol 2015; 6(1): 13-22 [PMID: 25685607 DOI: 10.4291/wjgp.v6.i1.13]
URL: https://www.wjgnet.com/2150-5330/full/v6/i1/13.htm
Number Citing Articles
1
SerahFunke Ige, MayowaJ Adeniyi, AlabiTimilehin Olayinka, IdowuChristiana Kehinde. Role of dietary maize formulations in the healing of experimental acetic acid induced ulcerative colitis in male ratsChinese Journal of Physiology 2020; 63(4): 156 doi: 10.4103/CJP.CJP_33_20
2
Stanko Petrovic, Slobodan Obradovic, Marijana Petrovic, Nemanja Rancic. Ulcerative Colitis - Etiology, Diagnosis, Diet, Special Populations, and the Role of Interventional Endoscopy2022;  doi: 10.5772/intechopen.102041
3
Mohamed A. Morsy, Sumeet Gupta, Anroop B. Nair, Katharigatta N. Venugopala, Khaled Greish, Mahmoud El-Daly. Protective Effect of Spirulina platensis Extract against Dextran-Sulfate-Sodium-Induced Ulcerative Colitis in RatsNutrients 2019; 11(10): 2309 doi: 10.3390/nu11102309
4
Ki-Uk Kim, Jisu Kim, Wan-Hoon Kim, Hyeyoung Min, Chang Hwan Choi. Treatments of inflammatory bowel disease toward personalized medicineArchives of Pharmacal Research 2021; 44(3): 293 doi: 10.1007/s12272-021-01318-6
5
Nicholas JD Gould, Katharine LM Davidson, Chuka U Nwokolo, Ramesh P Arasaradnam. A systematic review of the role of DNA methylation on inflammatory genes in ulcerative colitisEpigenomics 2016; 8(5): 667 doi: 10.2217/epi-2016-0006
6
Serena Longo, Marcello Chieppa, Luca G. Cossa, Chiara C. Spinelli, Marco Greco, Michele Maffia, Anna M. Giudetti. New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic StudiesProteomes 2020; 8(3): 18 doi: 10.3390/proteomes8030018
7
Emmanuel A. Adakudugu, Elvis O. Ameyaw, Ernest Obese, Robert P. Biney, Isaac T. Henneh, Douglas B. Aidoo, Elizabeth N. Oge, Isaac Y. Attah, David D. Obiri. Protective effect of bergapten in acetic acid-induced colitis in ratsHeliyon 2020; 6(8): e04710 doi: 10.1016/j.heliyon.2020.e04710
8
Jérémy Allary, Didier Fressard, Guy Malgras, Francine Foubert, Marie Savary. Résistance à l’atracurium et bloc neuromusculaire paradoxal à la néostigmine : description d’un cas cliniqueAnesthésie & Réanimation 2017; 3(2): 189 doi: 10.1016/j.anrea.2016.12.001
9
Ghady Rahhal, Mark Levine. Gastrointestinal Emergencies2019; : 325 doi: 10.1007/978-3-319-98343-1_94
10
Meng-Hui Zhang, Han Wang, Hong-Gang Wang, Xin Wen, Xiao-Zhong Yang. Effective immune-inflammation index for ulcerative colitis and activity assessmentsWorld Journal of Clinical Cases 2021; 9(2): 334-343 doi: 10.12998/wjcc.v9.i2.334
11
Anna Góra, Katarzyna Bąk-Drabik, Jolanta Porębska, Franciszek Halkiewicz, Katarzyna Ziora, Edyta Machura. Trudności w ustaleniu etiologii zmian płucnych u 15-letniej dziewczynki z wrzodziejącym zapaleniem jelita grubegoPediatria Polska 2017; 92(6): 770 doi: 10.1016/j.pepo.2017.07.002
12
Gabriele Dragoni, Tommaso Innocenti, Andrea Galli. Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?Digestive Diseases 2021; 39(3): 190 doi: 10.1159/000511641
13
Yu. M. Stepanov, I. V. Psareva, O. M. Tatarchuk, E. V. Zygalo, O. P. Petishko. LEVELS OF INTESTINAL INFLAMMATION MARKERS AS A DIAGNOSTIC CRITERION FOR FORMING A RISK GROUP FOR IDENTIFICATION OF SMALL INTESTINAL BACTERIAL OVERGROWTH IN ULCER COLIT Bulletin of Problems Biology and Medicine 2020; 4(2): 204 doi: 10.29254/2077-4214-2019-4-2-154-204-207
14
Angela M. Patterson. Soluble Syndecan-1: Does This Biomarker Address a Seemingly Insoluble Problem in Inflammatory Bowel Disease?Digestive Diseases and Sciences 2015; 60(8): 2222 doi: 10.1007/s10620-015-3669-x
15
Bruce E. Sands. Biomarkers of Inflammation in Inflammatory Bowel DiseaseGastroenterology 2015; 149(5): 1275 doi: 10.1053/j.gastro.2015.07.003
16
Olga V. Usoltseva, Andrey N. Surkov, Goar B. Movsisyan, Alexander S. Potapov, Elena A. Kulebina, Кirill A. Kulikov, Vladislav V. Chernikov. Correlation of Inflammatory Bowel Diseases with Liver Involvement Severity in Autoimmune Hepatobiliary Pathology: Cross-Sectional StudyCurrent Pediatrics 2022; 21(2): 105 doi: 10.15690/pf.v19i2.2407
17
Gerda C Leitner, Harald Vogelsang. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adultsWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 5-20 doi: 10.4292/wjgpt.v7.i1.5
18
Griet Debyser, Bart Mesuere, Lieven Clement, Jens Van de Weygaert, Pieter Van Hecke, Gwen Duytschaever, Maarten Aerts, Peter Dawyndt, Kris De Boeck, Peter Vandamme, Bart Devreese. Faecal proteomics: A tool to investigate dysbiosis and inflammation in patients with cystic fibrosisJournal of Cystic Fibrosis 2016; 15(2): 242 doi: 10.1016/j.jcf.2015.08.003
19
Mayu Uchihara, Jun Kato, Saya Tsuda, Takeichi Yoshida, Takao Maekita, Mikitaka Iguchi, Masayuki Kitano. Blood biomarkers reflect integration of severity and extent of endoscopic inflammation in ulcerative colitisJGH Open 2017; 1(3): 98 doi: 10.1002/jgh3.12017
20
Olfat G. Shaker, Marwa A. Ali, Tarek I. Ahmed, Othman M. Zaki, Doaa Y. Ali, Essam A. Hassan, Nada F. Hemeda, Marwa N. AbdelHafez. Association between LINC00657 andmiR‐106aserum expression levels and susceptibility to colorectal cancer, adenomatous polyposis, and ulcerative colitis in Egyptian populationIUBMB Life 2019; 71(9): 1322 doi: 10.1002/iub.2039
21
Mariya A. Borisova, Kseniya M. Achasova, Ksenia N. Morozova, Evgeniya N. Andreyeva, Ekaterina A. Litvinova, Anna A. Ogienko, Maryana V. Morozova, Mariya B. Berkaeva, Elena Kiseleva, Elena N. Kozhevnikova. Mucin-2 knockout is a model of intercellular junction defects, mitochondrial damage and ATP depletion in the intestinal epitheliumScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-78141-4
22
Waliza Ansar, Shyamasree Ghosh. Biology of C Reactive Protein in Health and Disease2016; : 67 doi: 10.1007/978-81-322-2680-2_4
23
Gary R Lichtenstein, Dermot P B McGovern. Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current StatusThe American Journal of Gastroenterology Supplements 2016; 3(3): 17 doi: 10.1038/ajgsup.2016.17
24
Javier P Gisbert, María Chaparro. Clinical Usefulness of Proteomics in Inflammatory Bowel Disease: A Comprehensive ReviewJournal of Crohn's and Colitis 2019; 13(3): 374 doi: 10.1093/ecco-jcc/jjy158
25
Yasmin Hadian, Daniel Fregoso, Chuong Nguyen, Michelle D. Bagood, Sara E. Dahle, Melanie G. Gareau, Roslyn Rivkah Isseroff. Microbiome‐skin‐brain axis: A novel paradigm for cutaneous woundsWound Repair and Regeneration 2020; 28(3): 282 doi: 10.1111/wrr.12800
26
Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?BIOCELL 2021; 45(3): 461 doi: 10.32604/biocell.2021.014332
27
Eniko Nagy, Ramona M. Rodriguiz, William C. Wetsel, Nancie J. MacIver, Laura P. Hale, Gunnar Loh. Reproduction and Growth in a Murine Model of Early Life-Onset Inflammatory Bowel DiseasePLOS ONE 2016; 11(4): e0152764 doi: 10.1371/journal.pone.0152764
28
Jihye Kim, Jaeyoung Chun, Changhyun Lee, Kyungdo Han, Seungho Choi, Jooyoung Lee, Hosim Soh, Kookhwan Choi, Seona Park, Eun Ae Kang, Hyun Jung Lee, Jong Pil Im, Joo Sung Kim. Increased risk of idiopathic pulmonary fibrosis in inflammatory bowel disease: A nationwide studyJournal of Gastroenterology and Hepatology 2020; 35(2): 249 doi: 10.1111/jgh.14838
29
Valeriya S. Tsvetkova, Alexander S. Potapov, Elena L. Semikina, Andrey P. Fisenko, Maksim M. Lokhmatov, Andrey N. Surkov, Anton O. Anushenko, Elena A. Kopyltsova, Tatyana N. Budkina, Svetlana S. Akulova. Noninvasive assessment of ulcerative colitis activity in childrenRussian Pediatric Journal 2021; 24(1): 12 doi: 10.46563/1560-9561-2021-24-1-12-19
30
Katrine Carlsen, Lene Buhl Riis, Henriette Elsberg, Louise Maagaard, Tine Thorkilgaard, Sveinung Wergeland Sørbye, Christian Jakobsen, Vibeke Wewer, Jon Florholmen, Rasmus Goll, Pia Munkholm. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitisScandinavian Journal of Gastroenterology 2018; 53(7): 825 doi: 10.1080/00365521.2018.1482956
31
Dawn Queen, Amin A. Hedayat, Cynthia Magro, Larisa J. Geskin. An unusual cause of bilateral orbital swelling: Immunoglobulin G4–related orbital disease arising in a patient with ulcerative colitisJAAD Case Reports 2019; 5(7): 634 doi: 10.1016/j.jdcr.2019.05.018
32
Matthew M. Philp, Howard M. Ross. The ASCRS Textbook of Colon and Rectal Surgery2016; : 771 doi: 10.1007/978-3-319-25970-3_45
33
Kimberly M. Anderson, C. Jane Welsh, Colin Young, Gwendolyn J. Levine, Sharon C. Kerwin, C. Elizabeth Boudreau, Ismael Reyes, Armando Mondragon, John F. Griffin, Noah D. Cohen, Jonathan M. Levine. Acute Phase Proteins in Cerebrospinal Fluid from Dogs with Naturally-Occurring Spinal Cord InjuryJournal of Neurotrauma 2015; 32(21): 1658 doi: 10.1089/neu.2015.3895
34
Anthony Croft, Anton Lord, Graham Radford-Smith. Markers of Systemic Inflammation in Acute Attacks of Ulcerative Colitis: What Level of C-reactive Protein Constitutes Severe Colitis?Journal of Crohn's and Colitis 2022; 16(7): 1089 doi: 10.1093/ecco-jcc/jjac014
35
Zhi-Zhi Wang, Ke Shi, Jie Peng. Serologic testing of a panel of five antibodies in inflammatory bowel diseases: Diagnostic value and correlation with disease phenotypeBiomedical Reports 2017; 6(4): 401 doi: 10.3892/br.2017.860
36
Kohki Okada, Hiroshi Itoh, Masaki Ikemoto. Serum complement C3 and α2-macroglobulin are potentially useful biomarkers for inflammatory bowel disease patientsHeliyon 2021; 7(3): e06554 doi: 10.1016/j.heliyon.2021.e06554
37
Heejeong Hong, Hyun-Kuk Song, Eun Sook Hwang, A. Reum Lee, Dong Soo Han, Seong-Eun Kim, Eok-Soo Oh. Up‐regulation of syndecan‐2 in proximal colon correlates with acute inflammationThe FASEB Journal 2019; 33(10): 11381 doi: 10.1096/fj.201900561R
38
Abdurrahman Sahin, Hakan Artas, Yesim Eroglu, Nurettin Tunc, Gulcan Oguz, Ulvi Demirel, Orhan Poyrazoglu, Mehmet Yalniz, Ibrahim Bahcecioglu. A Neglected Issue in Ulcerative Colitis: Mesenteric Lymph NodesJournal of Clinical Medicine 2018; 7(6): 142 doi: 10.3390/jcm7060142
39
Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim. Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based studyWorld Journal of Gastroenterology 2018; 24(42): 4798-4808 doi: 10.3748/wjg.v24.i42.4798
40
Nimisha Sarah Mathew, Serva Peddha Muthukumar, Bheemanakere Kempaiah Bettadaiah, Pradeep Singh Negi. Efficacy of a functional food ingredient from Ensete superbum Roxb. Cheesman peel in reducing the severity of ulcerative colitis in a murine modelFood & Function 2022; 13(6): 3732 doi: 10.1039/D1FO03365D
41
Laura Francesca Pisani, Manuela Moriggi, Cecilia Gelfi, Maurizio Vecchi, Luca Pastorelli. Proteomic insights on the metabolism in inflammatory bowel diseaseWorld Journal of Gastroenterology 2020; 26(7): 696-705 doi: 10.3748/wjg.v26.i7.696
42
Lizhi Zhang, Tsung-Teh Wu. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases2019; : 373 doi: 10.1007/978-3-030-15573-5_15
43
Ping Jin, Kui Wang, Canhua Huang, Edouard C. Nice. Mining the fecal proteome: from biomarkers to personalised medicineExpert Review of Proteomics 2017; 14(5): 445 doi: 10.1080/14789450.2017.1314786
44
Yu. M. Stepanov, I. V. Psareva, O. M. Tatarchuk, O. P. Petishko. DIAGNOSTIC VALUE OF LABORATORY AND FECAL BIOMARKERS FOR DETERMINING THE ACTIVITY OF ULCERATIVE COLITISBulletin of Problems Biology and Medicine 2019; 4(1): 158 doi: 10.29254/2077-4214-2019-4-1-153-158-162
45
Sofija I. Lugonja, Ivana L. Pantic, Tamara M. Milovanovic, Vesna M. Grbovic, Bojana M. Djokovic, Željko D. Todorovic, Stefan M. Simovic, Raša H. Medovic, Nebojsa D. Zdravkovic, Natasa D. Zdravkovic. Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet AggregationMedicina 2023; 59(3): 554 doi: 10.3390/medicina59030554
46
Uday C Ghoshal, Sushmita Rai, Akshay Kulkarni, Ankur Gupta. Prediction of outcome of treatment of acute severe ulcerative colitis using principal component analysis and artificial intelligenceJGH Open 2020; 4(5): 889 doi: 10.1002/jgh3.12342
47
Gary R Lichtenstein, Dermot P B McGovern. Using Markers in IBD to Predict Disease and Treatment Outcomes: Rationale and a Review of Current StatusThe American Journal of Gastroenterology Supplements 2016; 3(3): 17 doi: 10.1038/ajgs.2016.17
48
Brigida Barberio, Renata D’Incà, Sonia Facchin, Marianna Dalla Gasperina, Cedric Arsenè Fohom Tagne, Romilda Cardin, Matteo Ghisa, Greta Lorenzon, Carla Marinelli, Edoardo Vincenzo Savarino, Fabiana Zingone. Matrix Metalloproteinase 3 Predicts Therapeutic Response in Inflammatory Bowel Disease Patients Treated With InfliximabInflammatory Bowel Diseases 2020; 26(5): 756 doi: 10.1093/ibd/izz195
49
US Inflammatory Bowel Disease Prevalence: Surveillance Data from the U.S. National Health and Nutrition Examination SurveyPreventive Medicine Reports 2023; : 102173 doi: 10.1016/j.pmedr.2023.102173
50
Petra Weimers, Dorit Vedel Ankersen, Pia Munkholm. Biomarkers in Inflammatory Bowel Diseases2019; : 271 doi: 10.1007/978-3-030-11446-6_22
51
Radislav Nakov. New markers in ulcerative colitisClinica Chimica Acta 2019; 497: 141 doi: 10.1016/j.cca.2019.07.033
52
Ekaterina A. Postovalova, Olga V. Makarova, Anna M. Kosyreva, Dzhuliia S. Dzhalilova. Hypoxia is a key mechanism for regulating inflammation in ulcerative colitisRussian Open Medical Journal 2020; 9(1) doi: 10.15275/rusomj.2020.0101
53
Amandeep Singh, Uttam Kumar Mandal, Raj Kumar Narang. Development and In Vivo Evaluation of Pectin Based Enteric Coated Microparticles Loaded with Mesalamine and Saccharomyces boulardii for Management of Ulcerative ColitisASSAY and Drug Development Technologies 2022; 20(1): 22 doi: 10.1089/adt.2021.052
54
Nour Eissa, Hayam Hussein, Laëtitia Kermarrec, Omar Elgazzar, Marie-Helene Metz-Boutigue, Charles N. Bernstein, Jean-Eric Ghia. Chromofungin (CHR: CHGA47-66) is downregulated in persons with active ulcerative colitis and suppresses pro-inflammatory macrophage function through the inhibition of NF-κB signalingBiochemical Pharmacology 2017; 145: 102 doi: 10.1016/j.bcp.2017.08.013
55
Elizabeth A Spencer, Sonia M Davis, David R Mack, Brendan M Boyle, Anne M Griffiths, Neal S LeLeiko, Cary G Sauer, David J Keljo, James F Markowitz, Susan S Baker, Joel R Rosh, Robert N Baldassano, Maria Oliva-Hemker, Marian D Pfefferkorn, Anthony R Otley, Melvin B Heyman, Joshua D Noe, Ashish S Patel, Paul A Rufo, Keith Benkov, Jonathan Evans, Stephen Guthery, Michael Kappelman, Dedrick Moulton, Jennifer Strople, Boris Sudel, Prateek Wali, David Ziring, Vin Tangpricha, M Alison Marquis, Thomas D Walters, Margaret H Collins, Subra Kugathasan, Lee A Denson, Jeffrey S Hyams, Marla C Dubinsky. Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in ChildrenInflammatory Bowel Diseases 2018; 24(6): 1335 doi: 10.1093/ibd/izy009
56
Belinda De Simone, Justin Davies, Elie Chouillard, Salomone Di Saverio, Frank Hoentjen, Antonio Tarasconi, Massimo Sartelli, Walter L. Biffl, Luca Ansaloni, Federico Coccolini, Massimo Chiarugi, Nicola De’Angelis, Ernest E. Moore, Yoram Kluger, Fikri Abu-Zidan, Boris Sakakushev, Raul Coimbra, Valerio Celentano, Imtiaz Wani, Tadeja Pintar, Gabriele Sganga, Isidoro Di Carlo, Dario Tartaglia, Manos Pikoulis, Maurizio Cardi, Marc A. De Moya, Ari Leppaniemi, Andrew Kirkpatrick, Vanni Agnoletti, Gilberto Poggioli, Paolo Carcoforo, Gian Luca Baiocchi, Fausto Catena. WSES-AAST guidelines: management of inflammatory bowel disease in the emergency settingWorld Journal of Emergency Surgery 2021; 16(1) doi: 10.1186/s13017-021-00362-3
57
Jung Yoon Pyo, Sung Soo Ahn, Lucy Eunju Lee, Ha Na Choe, Jason Jungsik Song, Yong‐Beom Park, Sang‐Won Lee. Efficacy of the fibrosis index for predicting end‐stage renal disease in patients with antineutrophil cytoplasmic antibody‐associated vasculitisInternational Journal of Clinical Practice 2021; 75(4) doi: 10.1111/ijcp.13929
58
T.D. Zvyagintseva, A.V. Yaroshenko . Biological diagnosis of inflammatory bowel disease: current ideas and future achievements.Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2021; 2021(1): 103 doi: 10.15407/internalmed2021.01.103
59
Kenneth Daniel, Luis Vitetta, Maria A. Fiatarone Singh. Effects of olives and their constituents on the expression of ulcerative colitis: a systematic review of randomised controlled trialsBritish Journal of Nutrition 2022; 127(8): 1153 doi: 10.1017/S0007114521001999
60
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitisScandinavian Journal of Gastroenterology 2022; 57(5): 513 doi: 10.1080/00365521.2021.2022193
61
Yu. A. Khalitova, Yu. V. Myakisheva, S. E. Katorkin, P. S. Andreev, D. S. Gromova. Clinical and biochemical status of patients with ulcerative collitisBulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH) 2022; (5): 66 doi: 10.20340/vmi-rvz.2022.5.CLIN.7
62
Weiwei Jiang, Xuhang Li. Molecular Analysis of Inflammatory Bowel Disease: Clinically Useful Tools for Diagnosis, Response Prediction, and Monitoring of Targeted TherapyMolecular Diagnosis & Therapy 2015; 19(3): 141 doi: 10.1007/s40291-015-0142-7
63
Alicja Derkacz, Pawel Olczyk, Katarzyna Komosinska-Vassev. Diagnostic Markers for Nonspecific Inflammatory Bowel DiseasesDisease Markers 2018; 2018: 1 doi: 10.1155/2018/7451946